Búsqueda | Biblioteca Virtual en Salud

1.

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Bronstein, Jeff M; Paul, Kimberly; Yang, Laurice; Haas, Richard H; Shults, Clifford W; Le, Thuy; Ritz, Beate.

Mov Disord ; 30(6): 862-6, 2015 May.

Artículo en Inglés | MEDLINE | ID: mdl-25757798

2.

Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons.

Meurers, Bernhard H; Dziewczapolski, Gustavo; Shi, Tao; Bittner, Anton; Kamme, Fredrik; Shults, Clifford W.

J Neurosci ; 29(21): 6828-39, 2009 May 27.

Artículo en Inglés | MEDLINE | ID: mdl-19474310

3.

Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons.

Meurers, Bernhard H; Dziewczapolski, Gustavo; Bittner, Anton; Shi, Tao; Kamme, Fredrik; Shults, Clifford W.

Neurobiol Dis ; 34(1): 178-88, 2009 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-19320057

4.

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

Shults, Clifford W; Rockenstein, Edward; Crews, Leslie; Adame, Anthony; Mante, Michael; Larrea, Gabriel; Hashimoto, Makoto; Song, David; Iwatsubo, Takeshi; Tsuboi, Kyoko; Masliah, Eliezer.

J Neurosci ; 25(46): 10689-99, 2005 Nov 16.

Artículo en Inglés | MEDLINE | ID: mdl-16291942

5.

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.

Nichols, William C; Pankratz, Nathan; Hernandez, Dena; Paisán-Ruíz, Coro; Jain, Shushant; Halter, Cheryl A; Michaels, Veronika E; Reed, Terry; Rudolph, Alice; Shults, Clifford W; Singleton, Andrew; Foroud, Tatiana.

Lancet ; 365(9457): 410-2, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-15680455

6.

Therapeutic role of coenzyme Q(10) in Parkinson's disease.

Shults, Clifford W.

Pharmacol Ther ; 107(1): 120-30, 2005 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-15963354

7.

alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.

Shults, Clifford W; Barrett, Jennifer M; Fontaine, Deborah.

Neurosci Lett ; 405(3): 223-5, 2006 Sep 25.

Artículo en Inglés | MEDLINE | ID: mdl-16901642

8.

Mutations in DJ-1 are rare in familial Parkinson disease.

Pankratz, Nathan; Pauciulo, Michael W; Elsaesser, Veronika E; Marek, Diane K; Halter, Cheryl A; Wojcieszek, Joanne; Rudolph, Alice; Shults, Clifford W; Foroud, Tatiana; Nichols, William C.

Neurosci Lett ; 408(3): 209-13, 2006 Nov 20.

Artículo en Inglés | MEDLINE | ID: mdl-16997464

9.

The adult substantia nigra contains progenitor cells with neurogenic potential.

Lie, D Chichung; Dziewczapolski, Gustavo; Willhoite, Andrew R; Kaspar, Brian K; Shults, Clifford W; Gage, Fred H.

J Neurosci ; 22(15): 6639-49, 2002 Aug 01.

Artículo en Inglés | MEDLINE | ID: mdl-12151543

10.

Natural history of multiple system atrophy in the USA: a prospective cohort study.

Low, Phillip A; Reich, Stephen G; Jankovic, Joseph; Shults, Clifford W; Stern, Matthew B; Novak, Peter; Tanner, Caroline M; Gilman, Sid; Marshall, Frederick J; Wooten, Frederick; Racette, Brad; Chelimsky, Thomas; Singer, Wolfgang; Sletten, David M; Sandroni, Paola; Mandrekar, Jay.

Lancet Neurol ; 14(7): 710-9, 2015 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-26025783

11.

Treatments of Parkinson disease: circa 2003.

Shults, Clifford W.

Arch Neurol ; 60(12): 1680-4, 2003 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-14676041

12.

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Shults, Clifford W; Oakes, David; Kieburtz, Karl; Beal, M Flint; Haas, Richard; Plumb, Sandy; Juncos, Jorge L; Nutt, John; Shoulson, Ira; Carter, Julie; Kompoliti, Katie; Perlmutter, Joel S; Reich, Stephen; Stern, Matthew; Watts, Ray L; Kurlan, Roger; Molho, Eric; Harrison, Madaline; Lew, Mark.

Arch Neurol ; 59(10): 1541-50, 2002 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-12374491

13.

Coenzyme Q10 in neurodegenerative diseases.

Shults, Clifford W.

Curr Med Chem ; 10(19): 1917-21, 2003 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-12871093

14.

Mitochondrial dysfunction and possible treatments in Parkinson's disease--a review.

Shults, Clifford W.

Mitochondrion ; 4(5-6): 641-8, 2004 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-16120421

15.

Antioxidants as therapy for Parkinson's disease.

Shults, Clifford W.

Antioxid Redox Signal ; 7(5-6): 694-700, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-15890014

16.

Reexamination of the TEMPO Study.

Shults, Clifford W.

Arch Neurol ; 62(8): 1320; author reply 1321, 2005 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-16087778

17.

Clinical trials of coenzyme Q10 in neurological disorders.

Shults, Clifford W; Haas, Richard.

Biofactors ; 25(1-4): 117-26, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-16873936

18.

Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.

Beal, M Flint; Shults, Clifford W.

Biofactors ; 18(1-4): 153-61, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-14695931

19.

Measuring the effects of therapy in Parkinson disease.

Shults, Clifford W; Haas, Richard; Oakes, David; Kieburtz, Karl; Plumb, Sandra; Shoulson, Ira; Beal, M Flint; Juncos, Jorge; Nutt, John.

JAMA ; 291(20): 2430-1; author reply 2431, 2004 May 26.

Artículo en Inglés | MEDLINE | ID: mdl-15161889

20.

Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.

Lipp, Axel; Sandroni, Paola; Ahlskog, J Eric; Fealey, Robert D; Kimpinski, Kurt; Iodice, Valeria; Gehrking, Tonette L; Weigand, Stephen D; Sletten, David M; Gehrking, Jade A; Nickander, Kim K; Singer, Wolfgang; Maraganore, Demetrius M; Gilman, Sid; Wenning, Gregor K; Shults, Clifford W; Low, Phillip A.

Arch Neurol ; 66(6): 742-50, 2009 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-19506134

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Platelet mitochondrial activity and pesticide exposure in early Parkinson's disease.

Dopamine depletion induces distinct compensatory gene expression changes in DARPP-32 signal transduction cascades of striatonigral and striatopallidal neurons.

Dopamine depletion induced up-regulation of HCN3 enhances rebound excitability of basal ganglia output neurons.

Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.

Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease.

Therapeutic role of coenzyme Q(10) in Parkinson's disease.

alpha-synuclein from platelets is not phosphorylated at serine 129 in Parkinson's disease and multiple system atrophy.

Mutations in DJ-1 are rare in familial Parkinson disease.

The adult substantia nigra contains progenitor cells with neurogenic potential.

Natural history of multiple system atrophy in the USA: a prospective cohort study.

Treatments of Parkinson disease: circa 2003.

Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Coenzyme Q10 in neurodegenerative diseases.

Mitochondrial dysfunction and possible treatments in Parkinson's disease--a review.

Antioxidants as therapy for Parkinson's disease.

Reexamination of the TEMPO Study.

Clinical trials of coenzyme Q10 in neurological disorders.

Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease.

Measuring the effects of therapy in Parkinson disease.

Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure.